default author photo

Chao Niu

Jilin University (JLU) - Cancer Center

SCHOLARLY PAPERS

3

DOWNLOADS

169

TOTAL CITATIONS

0

Scholarly Papers (3)

Actions:
Email selected abstracts
1.

Cellular Immunotherapy Combined with Platinum-Based Chemotherapy Prolongs Survival for Non-Small Cell Lung Cancer Patients

Downloads 64 (924,743)

Cellular Immunotherapy Combined with Platinum-Based Chemotherapy Prolongs Survival for Non-Small Cell Lung Cancer Patients

Number of pages: 26 Posted: 04 Jan 2023
lei qian, Xiao Ding, fangqi Li, Huimin Tian, Xiao Chen, Fujun Han, Hongyi Wang, Wenqian Li, Chao Niu, Jianting Xu, Zhaozhi Li, Hua He and Jiuwei Cui
Jilin University (JLU) - First Hospital, Jilin University (JLU) - First Hospital, Jilin University (JLU) - First Hospital, Jilin University (JLU) - First Hospital, Jilin University (JLU) - First Hospital, Jilin University (JLU) - First Hospital, Jilin University (JLU) - First Hospital, Jilin University (JLU) - First Hospital, Jilin University (JLU) - Cancer Center, Jilin University (JLU) - First Hospital, Jilin University (JLU) - First Hospital, Jilin University (JLU) - First Hospital and Jilin University (JLU) - Cancer Center
Downloads 33 (1,311,254)

Abstract:

Loading...

Chemotherapy, Non-small cell lung cancer, Combination therapy, Adoptive immunotherapy

Cellular Immunotherapy Combined with Platinum-Based Chemotherapy Prolongs Survival for Non-Small Cell Lung Cancer Patients

Number of pages: 26 Posted: 19 Dec 2022
lei qian, Xiao Ding, fangqi Li, Huimin Tian, Xiao Chen, Fujun Han, Hongyi Wang, Wenqian Li, Chao Niu, Jianting Xu, Zhaozhi Li, Hua He and Jiuwei Cui
Jilin University (JLU) - First Hospital, Jilin University (JLU) - First Hospital, Jilin University (JLU) - First Hospital, Jilin University (JLU) - First Hospital, Jilin University (JLU) - First Hospital, Jilin University (JLU) - First Hospital, Jilin University (JLU) - First Hospital, Jilin University (JLU) - First Hospital, Jilin University (JLU) - Cancer Center, Jilin University (JLU) - First Hospital, Jilin University (JLU) - First Hospital, Jilin University (JLU) - First Hospital and Jilin University (JLU) - Cancer Center
Downloads 31 (1,341,098)

Abstract:

Loading...

Chemotherapy, Non-small cell lung cancer, Combination therapy, Adoptive immunotherapy

2.

Loss of Imprinting Control of the lncRNA H19-fetal Mitogen IGF2 Gene Cluster in the Decidual Microenvironment of Patients With Idiopathic Spontaneous Miscarriages

Number of pages: 35 Posted: 09 Aug 2021
Xue Wen, Qi Zhang, Lei Zhou, Zhaozhi Li, Xue Wei, Jiaomei Zhang, Hui Li, Yongchong Chen, Chao Niu, Ji Qu, Min Li, Jianting Xu, Zijun Xu, Xueling Cui, Songling Zhang, Yufeng Wang, Wei Li, Andrew R. Hoffman, Zhonghui Liu, Jifan Hu and Jiuwei Cui
Jilin University (JLU) - Key Laboratory of Organ Regeneration & Transplantation of the Ministry of Education, Jilin University (JLU) - Key Laboratory of Organ Regeneration & Transplantation of the Ministry of Education, Jilin University (JLU) - Key Laboratory of Organ Regeneration & Transplantation of the Ministry of Education, Jilin University (JLU) - Key Laboratory of Organ Regeneration & Transplantation of the Ministry of Education, Jilin University (JLU) - Key Laboratory of Organ Regeneration & Transplantation of the Ministry of Education, Jilin University (JLU) - Key Laboratory of Organ Regeneration & Transplantation of the Ministry of Education, Jilin University (JLU) - Key Laboratory of Organ Regeneration & Transplantation of the Ministry of Education, Jilin University (JLU) - Key Laboratory of Organ Regeneration & Transplantation of the Ministry of Education, Jilin University (JLU) - Cancer Center, Jilin University (JLU) - Key Laboratory of Organ Regeneration & Transplantation of the Ministry of Education, Jilin University (JLU) - Key Laboratory of Organ Regeneration & Transplantation of the Ministry of Education, Jilin University (JLU) - Key Laboratory of Organ Regeneration & Transplantation of the Ministry of Education, Jilin University (JLU) - Key Laboratory of Organ Regeneration & Transplantation of the Ministry of Education, Jilin University (JLU) - Department of Immunology, Jilin University (JLU) - Department of Obstetrics and Gynecology, Jilin University (JLU) - Key Laboratory of Organ Regeneration & Transplantation of the Ministry of Education, Jilin University (JLU) - Key Laboratory of Organ Regeneration & Transplantation of the Ministry of Education, Stanford University Medical School - VA Palo Alto Health Care System, Jilin University (JLU) - Department of Immunology, Stanford University Medical School - VA Palo Alto Health Care System and Jilin University (JLU) - Cancer Center
Downloads 62 (942,565)

Abstract:

Loading...

Miscarriage; long noncoding RNA; imprinting; epigenetics; DNA methylation, H3K27 methylation.

3.

Sintilimab Plus Autologous NK Cells as Second-Line Treatment for Advanced Non-Small-Cell Lung Cancer Previous Treated with Platinum-Containing Chemotherapy

Number of pages: 13 Posted: 21 May 2022
Jiuwei Cui, Lin Jia, Naifei Chen, Xiao Chen, Chao Niu, Ziling Liu, Kewei Ma, Nanya Wang, Lei Yang, Yuguang Zhao, Wei Song, Jin Lu, Chen Chen, Xiaofeng Cong, Xu Wang, Yinghui Xu, Guozhen Cui, Zengguang Liu, Rongrong Chen and Wei Li
Jilin University (JLU) - Cancer Center, Jilin University (JLU) - Cancer Center, Jilin University (JLU) - Cancer Center, Jilin University (JLU) - Cancer Center, Jilin University (JLU) - Cancer Center, Jilin University (JLU) - Cancer Center, Jilin University (JLU) - Cancer Center, Jilin University (JLU) - Cancer Center, Jilin University (JLU) - Cancer Center, Jilin University (JLU) - Cancer Center, Jilin University (JLU) - Cancer Center, Jilin University (JLU) - Cancer Center, Jilin University (JLU) - Cancer Center, Jilin University (JLU) - Cancer Center, Jilin University (JLU) - Cancer Center, Jilin University (JLU) - Cancer Center, Jilin University (JLU) - Cancer Center, Jilin University (JLU) - Cancer Center, Jilin University (JLU) - Cancer Center and Jilin University (JLU) - Cancer Center
Downloads 43 (1,145,425)

Abstract:

Loading...

Non-small-cell lung cancer, Natural killer (NK) cells, immunotherapy, pd-1 inhibitors